Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE recommends NHS use of Kymriah for second indication

pharmaceutical-technologyFebruary 03, 2019

Tag: acute lymphoblastic leukaemia , Kymriah , NICE , ​CAR-T Therapy

PharmaSources Customer Service